News Focus
News Focus
Followers 128
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: None

Monday, 08/01/2016 12:04:39 PM

Monday, August 01, 2016 12:04:39 PM

Post# of 12451

IGXT-DD for Newbies ..A Once in a lifetime here guys .

Undiscovered Intelgenx (IGXT) is definitely one of the most attractive and undervalued stock in the Biotech Sector . The Company has already 2 Drugs approved and another 2 Big Drugs close to FDA approval .BIG Partnership News could come any day for up to 3 Drugs for which IGXT got a Therm Sheet from a Global Pharma Company and there are another partnering discussion ongoing for 2 Drugs (see pipeline chart below) .Their unique Thin-film version of the Blockbuster Drug Cialis (Erectile Dysfunction) alone is worth $2-3 per share , NDA filing for the Drug coming before Year end .

IGXT has a ridiculous Market Cap of $33 Million which is a Big Joke for a Company with such a MEGA Product Pipeline , this Co has everything to be the next 10 Bagger minimum .GL



Intelgenx (IGXT)

Market Cap: $33 Million
Cash: $2.1 Million
Price: $0.52

Burn-Rate: $400k per Quarter
Shares Out : 63.6 Million


UPcoming Milestone :


Big Partnership imminent :

•Announced a development and commercialization term sheet with a global pharmaceutical company for up to three products. If entered into, IntelGenx expects the definitive agreement to be finalized in the second quarter of 2016


Product :Rizaport (Migraine)
•European Mktg Approval–November 2015
•Planned USA submission to FDA Q4/2016
•Expected USA launch Q2/2017


Product :Tadalafil (Erectile Dysfunction) a better Oral thin-film version of Blockbuster Drug Cialis
•505(b)(2) USA NDA submission in Q4/2016
•Expected USA launch Q4/2017


Product :Indicated for Opioid Dependence
•Awaiting FDA approval
•According to IMS data, the oral film market for opioid dependence was worth more than $1.4B US in 2014.


Presentation July 2016
http://s2.q4cdn.com/790425727/files/doc_presentations/2016/INTELGENX_July-6_2016-(1).pdf








Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today